Literature DB >> 6457803

[Concentrations of mezlocillin in cerebrospinal fluid in vira meningitis (author's transl)].

H G Hoffmann, D Förster, I Schoen.   

Abstract

The concentrations of mezlocillin in the cerebrospinal fluid were measured in ten patients with viral meningitis after a single infusion of 5 g lasting 30 minutes. One to two hours after infusion the CSF concentrations were between 0.1 mcg/ml and 1.6 mcg/ml, and thus exceeded the minimal inhibitory concentrations of Neisseria meningitidis and Diplococcus pneumoniae, the most common pathogens in bacterial meningitis in adults. The minimal inhibitory concentration of ampicillin-sensitive strains of Haemophilus influenzae was also attained. Further investigations must be carried out, in order to ascertain whether higher CSF concentrations are attained in bacterial meningitis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6457803     DOI: 10.1007/bf01639124

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  9 in total

Review 1.  [Antibacterial activity of mezlocillin and azlocillin/A survey (author's transl)].

Authors:  H Knothe
Journal:  Arzneimittelforschung       Date:  1979

2.  Azlocillin and mezlocillin: laboratory studies of their properties, including comparison with the antibacterial activity of other antibiotics.

Authors:  D S Reeves; M J Bywater; H A Holt; J M Broughall
Journal:  Arzneimittelforschung       Date:  1979

3.  Mezlocillin: in vitro studies of a new broad-spectrum penicillin.

Authors:  G P Bodey; T Pan
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

4.  [Prognosis of purulent meningitis with particular reference to the beginning of treatment and age of the patient (author's transl)].

Authors:  T Wegmann
Journal:  MMW Munch Med Wochenschr       Date:  1976-12-03

5.  Activity of azlocillin and mezlocillin against gram-negative organisms: comparison with other penicillins.

Authors:  R Wise; A P Gillett; J M Andrews; K A Bedford
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

6.  Treatment of childhood meningitis with mezlocillin.

Authors:  J Llorens-Terol; A Lobato; D Adam
Journal:  Arzneimittelforschung       Date:  1979

7.  Cerebrospinal fluid penetration of mezlocillin.

Authors:  J Modai; J Pierre; E Bergogne-Berezin; M F Avril
Journal:  Arzneimittelforschung       Date:  1979

8.  [In vitro activity of mezlocillin, azlocillin and carbenicillin against bacteroidaceae with particular reference to bacteroides fragilis (author's transl)].

Authors:  H Werner; C Krassemann; J Ungerechts; H J Schmitz
Journal:  Infection       Date:  1977       Impact factor: 3.553

9.  [Azlocillin and mezlocillin: two new semisynthetic acylureido-penicillins (author's transl)].

Authors:  H Lode; U Niestrath; P Koeppe; H Langmaack
Journal:  Infection       Date:  1977       Impact factor: 3.553

  9 in total
  1 in total

Review 1.  Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.

Authors:  Roland Nau; Fritz Sörgel; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.